The major goal of this proposal is to unveil non-infectious causes of preterm labor and birth and may lead to the development of a treatment – such as vitamin D, which is FDA-approved during pregnancy – to reduce the risk of preterm birth.
“T Cells and IL-9 Signaling at the Maternal-Fetal Interface in Preterm Labor and Birth”
Source of funding: NIH/NIAID
Award (all years): $2,797,376
Project dates: 8/17/24-6/30/29